Dahlia Henry
- Oncology
- Pulmonary and Respiratory Medicine
- Endocrinology, Diabetes and Metabolism
- Molecular Biology
- Cancer Research
- Co-authors
- S. Michael RothenbergMichael C. CoxLori J. WirthNatasha RekhtmanMark G. KrisRobert J. YoungRyan P. FrazierRobin Guo
- Topics
- Lung Cancer Treatments and Mutations (4 papers)Neuroblastoma Research and Treatments (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Dahlia Henry
7 papers receiving 114 citations
Peers
Comparison fields: 5 of 26
- Oncology 65
- Pulmonary and Respiratory Medicine 49
- Endocrinology, Diabetes and Metabolism 40
- Molecular Biology 18
- Cancer Research 16
Countries citing papers authored by Dahlia Henry
This map shows the geographic impact of Dahlia Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dahlia Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dahlia Henry more than expected).
Fields of papers citing papers by Dahlia Henry
This network shows the impact of papers produced by Dahlia Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dahlia Henry. The network helps show where Dahlia Henry may publish in the future.
Co-authorship network of co-authors of Dahlia Henry
This figure shows the co-authorship network connecting the top 25 collaborators of Dahlia Henry. A scholar is included among the top collaborators of Dahlia Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dahlia Henry. Dahlia Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | 27 | |
| 3 | 33 | |
| 4 | 14 | |
| 5 | [A Case of Pediatric Soft Tissue Sarcoma with LMNA-NTRK1 Gene Fusion Treated with Larotrectinib under Single Patient Expanded Access System]. | 3 |
| 6 | 4 | |
| 7 | Use of Erythropoiesis-stimulating Agents (ESAs) in Lung Cancer Patients: Study-level and Patient-level Meta-analyses of Safety Outcomes | 1 |
About Dahlia Henry
Dahlia Henry is a scholar working on Hematology, Cancer Research and Neurology, having authored 7 papers that have together received 115 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Neuroblastoma Research and Treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (40 citations), Oncology (65 citations) and Pulmonary and Respiratory Medicine (49 citations). Dahlia Henry has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include S. Michael Rothenberg, Michael C. Cox, Lori J. Wirth, Natasha Rekhtman, Mark G. Kris, Robert J. Young, Ryan P. Frazier, Robin Guo, Jochen K. Lennerz and Jason C. Chang. Their work appears in journals such as Journal of Clinical Oncology, Thyroid and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.